• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与初始非侵入性产前检测无结果后进行信息性重抽相关的因素。

Factors Associated With Informative Redraw After an Initial No Result in Noninvasive Prenatal Testing.

机构信息

UConn Health, Framingham, Connecticut; Natera, Inc, San Carlos, California; and Virtua Health, Voorhees, New Jersey.

出版信息

Obstet Gynecol. 2018 Aug;132(2):428-435. doi: 10.1097/AOG.0000000000002728.

DOI:10.1097/AOG.0000000000002728
PMID:29995728
Abstract

OBJECTIVE

Noninvasive prenatal testing (NIPT) sometimes fails to provide a test result, usually as a result of low cell-free DNA fetal fraction. We investigated how initial fetal fraction, maternal weight, gestational age, and time between blood sampling contribute to obtaining an informative result when a redraw is performed.

METHODS

We performed a retrospective data review of NIPT samples received between January and October 2016 by a commercial laboratory, where the initial blood draw did not yield a result and a second sample was drawn between 5 and 28 days after the initial sampling. We included cases with fetal fraction less than 2.8% (the threshold for "no result" in this laboratory) and those with higher fetal fraction but where the NIPT results could not be interpreted with high confidence.

RESULTS

For 4,018 cases in which a redraw was recommended, a result was obtained for the second sample in 2,835 cases (70.6%) (95% CI 69.1-72.0%). For the 2,959 cases with insufficient fetal fraction, there was a result for the second sample in 1,861 cases (62.9%) (95% CI 61.1-64.6%). For this subset, the average increase in fetal fraction was 1.2% with an average interval between draws of 14 days. Informative redraw rate was strongly dependent on maternal weight and fetal fraction measured at the first draw. Gestational age was not an important determinant. Informative redraw rate increased rapidly over the first 8 days after the initial draw and more slowly thereafter.

CONCLUSION

Based on fetal fraction in the initial sample, maternal weight, and interval between blood draws, women can be provided with a personalized estimate of their likelihood of a result on redraw. This should aid in the counseling of women faced with the choice of reattempting NIPT, conventional screening, or an invasive diagnostic test.

摘要

目的

非侵入性产前检测(NIPT)有时无法提供检测结果,通常是由于游离胎儿 DNA 分数较低所致。我们研究了当重新采血时,初始胎儿分数、产妇体重、妊娠龄和两次采血之间的时间如何有助于获得有意义的结果。

方法

我们对一家商业实验室在 2016 年 1 月至 10 月间收到的 NIPT 样本进行了回顾性数据分析,这些初始血样未得出结果,且在初次采血后 5 至 28 天之间采集了第二份血样。我们纳入了胎儿分数小于 2.8%(本实验室“无结果”的阈值)的病例,以及那些胎儿分数较高但无法进行高可信度解读的病例。

结果

在建议进行重新采血的 4018 例病例中,有 2835 例(70.6%)(95%CI 69.1-72.0%)获得了第二份血样的结果。在 2959 例胎儿分数不足的病例中,有 1861 例(62.9%)(95%CI 61.1-64.6%)获得了第二份血样的结果。对于这部分病例,平均胎儿分数增加了 1.2%,两次采血之间的平均间隔为 14 天。有意义的重新采血率与初次采血时的产妇体重和胎儿分数密切相关。妊娠龄不是一个重要的决定因素。有意义的重新采血率在初始采血后 8 天内迅速增加,此后增加速度较慢。

结论

根据初始样本中的胎儿分数、产妇体重和采血间隔,可向女性提供其重新采血时获得结果的可能性的个性化估计。这将有助于为面临重新尝试 NIPT、常规筛查或有创性诊断性检查的女性提供咨询。

相似文献

1
Factors Associated With Informative Redraw After an Initial No Result in Noninvasive Prenatal Testing.与初始非侵入性产前检测无结果后进行信息性重抽相关的因素。
Obstet Gynecol. 2018 Aug;132(2):428-435. doi: 10.1097/AOG.0000000000002728.
2
Combining the use of a fetal fraction-based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for fetal aneuploidy.将基于胎儿比例的风险算法与非侵入性产前检测中信息丰富的重新检测概率相结合,用于胎儿非整倍体检测。
J Genet Couns. 2020 Oct;29(5):800-806. doi: 10.1002/jgc4.1208. Epub 2019 Dec 23.
3
Obesity and no call results: optimal timing of cell-free DNA testing and redraw.肥胖与无结果召回:游离 DNA 检测和重抽的最佳时机
Am J Obstet Gynecol. 2021 Oct;225(4):417.e1-417.e10. doi: 10.1016/j.ajog.2021.04.212. Epub 2021 Apr 8.
4
Validation of an Enhanced Version of a Single-Nucleotide Polymorphism-Based Noninvasive Prenatal Test for Detection of Fetal Aneuploidies.基于单核苷酸多态性的无创产前检测增强版用于检测胎儿非整倍体的验证
Fetal Diagn Ther. 2016;40(3):219-223. doi: 10.1159/000442931. Epub 2016 Mar 31.
5
Clinical experience across the fetal-fraction spectrum of a non-invasive prenatal screening approach with low test-failure rate.在具有低检测失败率的非侵入性产前筛查方法的胎儿分数范围内的临床经验。
Ultrasound Obstet Gynecol. 2020 Sep;56(3):422-430. doi: 10.1002/uog.21904.
6
Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction.爱尔兰游离胎儿 DNA 筛查用于胎儿非整倍体检测:胎儿细胞浓度不足的检测结果观察性研究。
Eur J Obstet Gynecol Reprod Biol. 2023 Nov;290:143-149. doi: 10.1016/j.ejogrb.2023.09.023. Epub 2023 Sep 27.
7
[Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].[通过平行大规模测序检测孕妇血液中的无创产前检测(NIPT)。墨西哥女性的初步经验及文献综述]
Ginecol Obstet Mex. 2015 May;83(5):277-88.
8
A proof-of-concept study on the effects of low total cfDNA content and solutions to increase the NIPT trisomy 21 detection rate.低总 cfDNA 含量的概念验证研究及其提高 NIPT 21 三体检测率的解决方案。
J Clin Lab Anal. 2020 Feb;34(2):e23035. doi: 10.1002/jcla.23035. Epub 2019 Sep 30.
9
Factors associated with obtaining results on repeat cell-free DNA testing in samples redrawn due to insufficient fetal fraction.与因胎儿游离DNA比例不足而重新采集的样本进行重复检测结果相关的因素。
J Matern Fetal Neonatal Med. 2020 Dec;33(23):4010-4015. doi: 10.1080/14767058.2019.1594190. Epub 2019 Mar 27.
10
Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.短 cfDNA 片段测序可提高无创产前检测中胎儿 DNA 比例。
Am J Obstet Gynecol. 2019 Oct;221(4):345.e1-345.e11. doi: 10.1016/j.ajog.2019.05.023. Epub 2019 May 21.

引用本文的文献

1
Hierarchical Classification of Factors Associated With Noninvasive Prenatal Testing Failures and Its Impact on Pregnancy Outcomes.与无创产前检测失败相关因素的分层分类及其对妊娠结局的影响
Matern Fetal Med. 2024 Oct 11;6(4):215-224. doi: 10.1097/FM9.0000000000000248. eCollection 2024 Oct.
2
Cell-free DNA test for fetal chromosomal abnormalities in multiple pregnancies.游离胎儿 DNA 检测在多胎妊娠胎儿染色体异常中的应用。
Acta Obstet Gynecol Scand. 2024 Sep;103(9):1799-1807. doi: 10.1111/aogs.14901. Epub 2024 Jun 25.
3
Insights into non-informative results from non-invasive prenatal screening through gestational age, maternal BMI, and age analyses.
通过对孕龄、母体 BMI 和年龄进行分析,深入了解非侵入性产前筛查的非信息性结果。
PLoS One. 2024 Mar 7;19(3):e0280858. doi: 10.1371/journal.pone.0280858. eCollection 2024.
4
Association between fetal fraction of cell-free DNA and adverse pregnancy outcomes.游离DNA的胎儿分数与不良妊娠结局之间的关联。
Arch Gynecol Obstet. 2024 Aug;310(2):1037-1048. doi: 10.1007/s00404-024-07443-z. Epub 2024 Mar 5.
5
White blood cell count affects fetal fraction and test failure rates in noninvasive prenatal screening.白细胞计数影响无创产前筛查中的胎儿游离DNA比例和检测失败率。
Front Med (Lausanne). 2023 Feb 2;10:1088745. doi: 10.3389/fmed.2023.1088745. eCollection 2023.
6
Additional value of advanced ultrasonography in pregnancies with two inconclusive cell-free DNA draws. 高级超声在两次无细胞游离 DNA 检测结果不确定的妊娠中的附加价值。
Prenat Diagn. 2022 Oct;42(11):1358-1367. doi: 10.1002/pd.6238. Epub 2022 Sep 26.
7
Chromosomal phase improves aneuploidy detection in non-invasive prenatal testing at low fetal DNA fractions.染色体相提高了在低胎儿 DNA 分数的非侵入性产前检测中的非整倍体检测。
Sci Rep. 2022 Jul 14;12(1):12025. doi: 10.1038/s41598-022-14049-5.
8
Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review.影响无创产前筛查中胎儿游离DNA比例的因素:综述
Front Pediatr. 2022 Jan 27;10:812781. doi: 10.3389/fped.2022.812781. eCollection 2022.
9
Lipid Metabolism Affects Fetal Fraction and Screen Failures in Non-invasive Prenatal Testing.脂质代谢影响无创产前检测中的胎儿游离DNA比例及筛查失败情况。
Front Med (Lausanne). 2022 Jan 12;8:811385. doi: 10.3389/fmed.2021.811385. eCollection 2021.
10
Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.基于游离细胞 DNA 测序的无创性产前检测的性能:36456 例单胎和多胎妊娠的经验。
BMC Med Genomics. 2021 Mar 30;14(1):93. doi: 10.1186/s12920-021-00941-y.